Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005;105(11):24-9.

[Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder]

[Article in Russian]
Iu A Aleksandrovskiĭ, A S Avedisova, I V Boev, A O Bukhanovkskiĭ, V M Voloshin, B D Tsygankov, B K Shamreĭ
  • PMID: 16329631
Clinical Trial

[Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder]

[Article in Russian]
Iu A Aleksandrovskiĭ et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2005.

Abstract

The results of a multicenter study of coaxil in the treatment of 90 patients with posttraumatic stress disorder (PTSD) are summarized. Two dosages of the drug, 75 mg daily (44 patients) and 37.5 mg daily (46 patients) have been compared. Coaxil efficacy was estimated with the Clinician Administered PTSD Scale (CAPS) and Hamilton depression scale (HAM-D). High efficacy of coaxil was shown, with 76.7 and 75.6% responders, respectively, for the dosages used. The optimum one proved to be 37.5 mg daily, which is congruent to the standard dose in the treatment of depression and provides not only the efficacy but tolerability of coaxil. The coaxil efficacy depended on a PTSD type: the drug was more effective in chronic PTSD that, in the authors' opinion, might be related to its antidepressant action.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

MeSH terms

LinkOut - more resources